Get started
Author

Matteo Paolinelli

Observed names: M. Paolinelli, Paolinelli Matteo, Paolinelli, Matteo
ORCID: 0000-0001-6488-5491
Observed ORCID: 0000-0001-6488-5491
OpenAlex ID: A5028409198
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
2023 · Federico Diotallevi, Helena Gioacchini, et al. · International Journal of Molecular Sciences · 106
PDF
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
2022 · Federico Diotallevi, Anna Campanati, et al. · Nutrients · 59
PDF
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone
2019 · Elisa Molinelli, Matteo Paolinelli, et al. · Expert Opinion on Drug Metabolism & Toxicology · 57
Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis
2019 · Anna Campanati, Matteo Paolinelli, et al. · Expert Opinion on Drug Metabolism & Toxicology · 41
Latest combination therapies in psoriasis: Narrative review of the literature
2022 · Federico Diotallevi, Matteo Paolinelli, et al. · Dermatologic Therapy · 36
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
2020 · Elisa Molinelli, Anna Campanati, et al. · Dermatology and Therapy · 34
PDF
New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
2022 · Paolinelli Matteo, Diotallevi Federico, et al. · Pharmaceutics · 24
PDF
Safety update of etanercept treatment for moderate to severe plaque psoriasis
2020 · Anna Campanati, Federico Diotallevi, et al. · Expert Opinion on Drug Safety · 22
Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA ( EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real‐life clinical practice) study
2021 · Delia Colombo, Luca Bianchi, et al. · Dermatologic Therapy · 21
Active implications for dermatologists in ‘SARS‐CoV‐2 ERA’: Personal experience and review of literature
2020 · A. Campanati, V. Brisigotti, et al. · Journal of the European Academy of Dermatology and Venereology · 20
PDF
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis)
2024 · D. Orsini, M. Megna, et al. · Journal of Dermatological Treatment · 17
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature
2022 · Anna Campanati, Emanuela Martina, et al. · Toxins · 15
PDF
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
2021 · Emanuela Zagni, Luca Bianchi, et al. · BMC Health Services Research · 14
PDF
Novel Therapeutic Approaches and Targets for the Treatment of Neutrophilic Dermatoses, Management of Patients with Neutrophilic Dermatoses and Future Directions in the Era of Biologic Treatment
2020 · Elisa Molinelli, Valerio Brisigotti, et al. · Current Pharmaceutical Biotechnology · 11
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions
2022 · Giulia Radi, Renato Rossi, et al. · Journal of the European Academy of Dermatology and Venereology · 7
Bullous Sweet’s syndrome in a patient with ulcerative colitis: a rare case report
2020 · Melania Giannoni, Giulio Rizzetto, et al. · Acta Dermatovenerologica Alpina Pannonica et Adriatica · 7
PDF
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness
2024 · Andrea Marani, Helena Gioacchini, et al. · Toxins · 6
PDF
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study
2021 · Anna Campanati, Federico Diotallevi, et al. · European Journal of Dermatology · 6
PDF
The use of the internet by outpatients in dermatology: a multicentric, observational and cross‐sectional study on frequency, motivations and feedback
2021 · M. Corazza, R. Forconi, et al. · Journal of the European Academy of Dermatology and Venereology · 5
PDF
Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease
2020 · Emanuela Martina, Federico Diotallevi, et al. · Current Pharmaceutical Biotechnology · 5
Potential drug–drug interactions with mitogen-activated protein kinase (MEK) inhibitors used to treat melanoma
2023 · A. Marani, H. Gioacchini, et al. · Expert Opinion on Drug Metabolism & Toxicology · 4
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3?
2020 · Emanuela Martina, Anna Campanati, et al. · Dermatitis · 3
Buschke–Ollendorff syndrome in a 6-year-old patient: clinical and histopathological aspects of a rare disease
2020 · Federico Diotallevi, Oriana Simonetti, et al. · Acta Dermatovenerologica Alpina Pannonica et Adriatica · 3
PDF
Global coronavirus pandemic ( SARS‐CoV ‐2): Past , present , and future of pediatric dermatology
2020 · Oriana Simonetti, Federico Diotallevi, et al. · Dermatologic Therapy · 2
A new approach in monitoring blood tests in anti-tumour necrosis factor-α therapies in psoriasis
2023 · Andrea Conti, Matteo Paolinelli · British Journal of Dermatology
Works count: 28
Citation count: 525
H-index: 13
I10-index: 14
Year
Topic
Type